Validation of a Next-Generation Sequencing Assay for Clinical Molecular Oncology

Currently, oncology testing includes molecular studies and cytogenetic analysis to detect genetic aberrations of clinical significance. Next-generation sequencing (NGS) allows rapid analysis of multiple genes for clinically actionable somatic variants. The WUCaMP assay uses targeted capture for NGS...

詳細記述

保存先:
書誌詳細
出版年:J Mol Diagn
主要な著者: Cottrell, Catherine E., Al-Kateb, Hussam, Bredemeyer, Andrew J., Duncavage, Eric J., Spencer, David H., Abel, Haley J., Lockwood, Christina M., Hagemann, Ian S., O’Guin, Stephanie M., Burcea, Lauren C., Sawyer, Christopher S., Oschwald, Dayna M., Stratman, Jennifer L., Sher, Dorie A., Johnson, Mark R., Brown, Justin T., Cliften, Paul F., George, Bijoy, McIntosh, Leslie D., Shrivastava, Savita, Nguyen, TuDung T., Payton, Jacqueline E., Watson, Mark A., Crosby, Seth D., Head, Richard D., Mitra, Robi D., Nagarajan, Rakesh, Kulkarni, Shashikant, Seibert, Karen, Virgin, Herbert W., Milbrandt, Jeffrey, Pfeifer, John D.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Investigative Pathology 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762937/
https://ncbi.nlm.nih.gov/pubmed/24211365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2013.10.002
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料